Skip to main content
Side panel
Bascom Palmer
SPECIALTIES
Cataracts and Intraocular Lenses
Comprehensive Ophthalmology
Corneal and External Diseases
Glaucoma
Neuro-Ophthalmology
Ocular Oncology
Ophthalmic Pathology
Ophthalmic Plastic and Reconstructive Surgery
Pediatric Ophthalmology and Strabismus
Retina and Vitreous Diseases
Uveitis
FILTER BY
Online Grand Rounds
Medical Student Education
Ophthalmic Images
Other Lectures
Surgical Videos
SEARCH
Search
Close
Search
Toggle search input
guest access (
Log in
)
Best of Angiogenesis, Exudation, and Degeneration 2025 – Virtual Edition
Home
Courses
Retina and Vitreous Diseases
Angio020825
Description
Treatment Response in Sham Eyes Initiating Pegcetacoplan Treatment in GA due to AMD at 12 Months in the GALE Extension by Dilsher S. Dhoot, MD
Treatment Response in Sham Eyes Initiating Pegcetacoplan Treatment in GA due to AMD at 12 Months in the GALE Extension by Dilsher S. Dhoot, MD
Click
https://youtu.be/PAkKpsAixIg
link to open resource.
Angio020825
Description
Home
Calendar
◄ Analysis of AREDS Vitamins on Geographic Atrophy Growth: Insights from the OAKS and DERBY Studies by Nathan C. Steinle, MD
Jump to...
Jump to...
Philip J. Rosenfeld, MD, PhD
Harry W. Flynn, Jr., MD
Thomas A. Albini, MD
Updated Guidelines for Imaging the Choriocapillaris in AMD Using Swept-Source OCT Angiography by Alessandro Berni, MD
Choriocapillaris Perfusion and the Appearance of Choroidal Hypertransmission Defects in AMD by Sara Beqiri, MBBS
Ophthalmic Artery Angioplasty for Geographic Artery: Results of A Pilot Device Study by Mario J. Saravia, MD, PhD
Efficacy and Safety of Complement Factor B Antisense, IONIS-FB-LRx, in Geographic Atrophy due to Age-Related Macular Degeneration: Results of the Phase 2 GOLDEN Study by Charles C. Wykoff, MD, PhD
Imaging Biomarkers in the Lumithera Trial of Photobiomodulation to Treat Dry AMD by Glenn J. Jaffe, MD
Analysis of AREDS Vitamins on Geographic Atrophy Growth: Insights from the OAKS and DERBY Studies by Nathan C. Steinle, MD
Treatment of Subfoveal Geographic Atrophy with Pegcetacoplan by David S. Boyer, MD
Real-World Efficacy of Intravitreal Pegcetacoplan in AMD by Mengxi Shen, MD, PhD
Real-World Safety of Intravitreal Pegcetacoplan in AMD by Philip J. Rosenfeld, MD, PhD
Longitudinal Pivotal Home OCT Trial to Compare Visualization of nvAMD Biomarkers with In-Office OCT by Jeffrey S. Heier, MD
Cross-Sectional Pivotal Home OCT Trial to Compare Performance of AI- Enabled Algorithms with Human Graders in nvAMD by Anat Loewenstein, MD
Real-World Efficacy and Safety of Faricimab in nAMD: First Time Three-Year Results of the TRUCKEE Study by Arshad M. Khanani, MD, MA, FASRS
What’s New with MacTel2? by Martin Friedlander, MD, PhD
Intraocular Drug Delivery Lasting Over a Decade: Ciliary Neurotrophic Factor (CNTF) Secreted by Encapsulated Cell Technology Implants (NT-501) Treating Patients with Retinal Degenerative Disorders by Thomas A. Albini, MD
Treatment of Subfoveal Geographic Atrophy with Pegcetacoplan by David S. Boyer, MD ►